神奇制药 (600613.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.0x

Market Cap

CNY 5.29B

MomentumView details →

1D Return

+10.00%

YTD Return

+48.60%

RSI (14)

55.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

30.0x

Market Cap

CNY 5.29B

RSI (14)

55.5

MomentumView details →

1D Return

+10.00%

YTD Return

+48.60%

ProfitabilityView details →

Gross Margin

44.69%

Net Margin

1.91%

EBITDA Margin

7.89%

ROE (TTM)

1.55%

ROA (TTM)

1.19%

Asset Turnover

0.61x

GrowthView details →

Revenue YoY

−3.01%

EPS YoY

−47.39%

FCF YoY

+89.47%

Revenue CAGR 3Y

−6.50%

EPS CAGR 3Y

−8.04%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.03x

Current Ratio

2.61x

Quick Ratio

2.25x

Div Yield

0.78%

Div Rate

CNY 0.07

Div Growth 1Y

−53.33%

Financials snapshotView financials →

Revenue (TTM)

1.90B

Net Income (TTM)

36.13M

Op. CF (TTM)

193.79M

Latest newsMore news →

Shenqi Pharmaceutical released its 2026 semi-annual report, reporting net profit of 21.9656 million yuan, down 33.05% year-on-year.7d ago

Similar companies

Grifols, S.A.GRFS 广誉远600771.SH Impact Therap-b07630.HK Tong Ren Tang Technologies Co. Ltd.01666.HK Luye Pharma Group Ltd.02186.HK Organon & Co.OGN Find similar companies →

Latest newsMore news →

Shenqi Pharmaceutical released its 2026 semi-annual report, reporting net profit of 21.9656 million yuan, down 33.05% year-on-year.7d ago